The invention provides 11β-hydroxyandrosta-4-ene-3-one compounds of Formula I, or physiologically acceptable salts or solvates thereof:
wherein R
4
represents a moiety selected from a group consisting of (A), (B) and (C), with a proviso that when R
4
represents moiety (C), Z is S: